At a glance
ClinicalIndex Comparison RecordN/ACompleted· 86 enrolled
Drug / intervention
QuickFlex Micro Model 1258T Left Heart Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
QuickFlex Micro Model 1258T Left Heart Pacing Lead
In Brief
A clinical study evaluating QuickFlex Micro Model 1258T Left Heart Lead for Heart Failure. Completed, enrolled 86 participants across 13 sites.
Detailed Summary
This is a prospective, multi-center non-randomized clinical study to evaluate the safety and efficacy of the QuickFlex Micro Model 1258T left ventricular lead in a heart failure patient population. The study will be conducted at a maximum of 20 investigational centers located in the United States and a total of 68 patients will be enrolled.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 2008
Enrollment StartOct 2008
Primary CompletionJun 2009
Study CompletionMay 2010
TodayJul 2026
First PostedOct 1, 2008
Enrollment StartOct 1, 2008
Primary CompletionJun 1, 2009
Study CompletionMay 1, 2010
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 17.8 years ago
Interventions
QuickFlex Micro Model 1258T Left Heart Leaddevice
Implantation of QuickFlex Micro 1258T left heart lead in combination with a CRT-D system.